天星医疗终止科创板IPO 原拟募资8.8亿元

Core Viewpoint - The Shanghai Stock Exchange has decided to terminate the review of Beijing Tianxing Medical Co., Ltd.'s application for an initial public offering (IPO) on the Sci-Tech Innovation Board due to the withdrawal of the application by its sponsor, China International Capital Corporation [1][3]. Company Overview - Tianxing Medical is an innovative medical device company specializing in sports medicine, focusing on the research, development, production, and sales of sports medicine implants, active devices, consumables, and surgical tools, providing comprehensive clinical solutions for patients and doctors [3]. IPO Details - Tianxing Medical initially planned to raise 879.5193 million yuan (approximately 87.95 million) through the IPO, with the funds allocated for the Suzhou Smart Factory project, product research and development, and to supplement working capital [3][4]. - The investment breakdown for the planned projects is as follows: - Suzhou Smart Factory Project: 440.1185 million yuan - Product Research and Development Project: 219.4008 million yuan - Supplementing Working Capital: 220 million yuan - Total: 879.5193 million yuan [4]. Sponsorship Information - The main sponsor for Tianxing Medical's IPO was China International Capital Corporation, with representatives Xu Min and Ji Yukan. China Galaxy Securities served as the co-sponsor [5].